Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.160 | 7 | 1087240 | 5 prime UTR variant | G/A | snv | 4.6E-02 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.080 | 7 | 1091775 | missense variant | C/T | snv | 0.21 | 0.19 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.925 | 0.080 | 7 | 1091775 | missense variant | C/T | snv | 0.21 | 0.19 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.925 | 0.080 | 7 | 1091775 | missense variant | C/T | snv | 0.21 | 0.19 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.925 | 0.080 | 7 | 1091775 | missense variant | C/T | snv | 0.21 | 0.19 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.925 | 0.080 | 7 | 1091775 | missense variant | C/T | snv | 0.21 | 0.19 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.040 | 7 | 1091720 | 5 prime UTR variant | T/A;C | snv | 5.5E-06; 0.62 |
|
Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.080 | 7 | 1086257 | intron variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.882 | 0.080 | 7 | 1086257 | intron variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.882 | 0.080 | 7 | 1086257 | intron variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.882 | 0.080 | 7 | 1086257 | intron variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.882 | 0.080 | 7 | 1086257 | intron variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.882 | 0.080 | 7 | 1086257 | intron variant | A/G;T | snv |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.240 | 7 | 1087023 | 5 prime UTR variant | G/A | snv | 0.29 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.240 | 7 | 1087023 | 5 prime UTR variant | G/A | snv | 0.29 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.240 | 7 | 1087023 | 5 prime UTR variant | G/A | snv | 0.29 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.240 | 7 | 1087023 | 5 prime UTR variant | G/A | snv | 0.29 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.827 | 0.240 | 7 | 1087023 | 5 prime UTR variant | G/A | snv | 0.29 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.827 | 0.240 | 7 | 1087023 | 5 prime UTR variant | G/A | snv | 0.29 |
|
0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.827 | 0.240 | 7 | 1087023 | 5 prime UTR variant | G/A | snv | 0.29 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.040 | 7 | 1093035 | missense variant | C/G;T | snv | 0.11; 6.7E-05 |
|
Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2019 | 2019 |